Non-interventional study on uncontrolled hypertensive patients for evaluating efficacy of candesartan cilexetil as monotherapy or add-on therapy
Phase of Trial: Phase IV
Latest Information Update: 18 Aug 2010
At a glance
- Drugs Candesartan cilexetil (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Acronyms PERFORM
- Sponsors AstraZeneca
- 18 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Aug 2010 Actual end date (Feb 2008) added as reported by ClinicalTrials.gov.
- 08 Jan 2008 New trial record.